Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center
Recruiting - verified February 2016

York Study of Unloading Shoes for Vascular Intermittent Claudication

Conditions:   Intermittent Claudication;   Peripheral Arterial Disease
Interventions:   Device: Unloading shoes;   Device: Unadapted control shoe
Sponsors:   York Teaching Hospitals NHS Foundation Trust;   University of York;   York St John University;   University of Salford
Recruiting - verified January 2016

Fycompa in Subjects With Small Fiber Neuropathy (SFN)

Condition:   Neuropathy, Small Fiber
Interventions:   Drug: Fycompa;   Drug: Placebo
Sponsors:   PNA Center for Neurological Research;   Eisai Inc.
Active, not recruiting - verified January 2016

Oral Nutritional Supplement in Reducing Surgical Site Infections

Conditions:   Peripheral Vascular Disease;   Claudication
Intervention:   Dietary Supplement: Arginine enriched oral nutritional supplement
Sponsors:   University of Limerick;   UL Hospitals, Limerick
Recruiting - verified February 2016

EverFlex Post Approval Study

Conditions:   Peripheral Arterial Disease;   Lower Extremity Arterial Disease
Intervention:   Device: EverFlex™ Self-Expanding Peripheral Stent System
Sponsor:   Medtronic Endovascular
Recruiting - verified January 2016

Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers

Conditions:   Type I Diabetes Mellitus With Ulcer;   Type II Diabetes Mellitus With Ulcer
Intervention:   Biological: ABMD-MSC
Sponsor:   Sheba Medical Center
Not yet recruiting - verified January 2016

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Conditions:   Intermittent Claudication;   Peripheral Artery Disease
Interventions:   Biological: PLX-PAD Low dose;   Biological: PLX-PAD high doses;   Biological: Double Placebo;   Biological: high dose +Placebo
Sponsor:   Pluristem Ltd.
Recruiting - verified February 2016

Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients

Condition:   Vascular Diseases
Intervention:  
Sponsor:   York Teaching Hospitals NHS Foundation Trust
Completed - verified February 2015

Study of SilverHawk®/TurboHawk® in Lower Extremity Vessels (DEFINITIVE™ LE)

Conditions:   Peripheral Arterial Disease;   Claudication;   Critical Limb Ischemia
Intervention:   Device: SilverHawk Peripheral Plaque Excision System
Sponsor:   Medtronic Endovascular
Completed - verified January 2016

Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome

Conditions:   Post Thrombotic Syndrome;   Deep Vein Thrombosis;   Venous Stasis Syndrome;   Venous Insufficiency;   Postphlebitic Syndrome
Intervention:   Device: VeinOPlus
Sponsors:   Stephan Moll, MD;   University of North Carolina, Chapel Hill;   VeinoPlus USA
Completed - verified February 2016